Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple mouthwash help fight gum disease? new study aims to find out

NCT ID NCT07257887

Disease control Sponsor: ENIKAM d.o.o. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a hydrogen peroxide mouth rinse (OROXID®) can improve gum health when used alongside standard dental cleaning. About 90 adults with moderate-to-severe gum disease will use either a 1.5% or 3% rinse or a control rinse for 12 weeks. The goal is to see if it reduces pocket depth and bleeding compared to standard care alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Systemically healthy participants aged 18 years or older. 2. Generalized periodontitis, Stage III, Grade B. 3. Presence of three or more periodontal pockets deeper than 5 mm. 4. At least 16 natural teeth (excluding wisdom teeth). 5. Ability to comply with oral hygiene instructions following the intervention. 6. Signed informed consent form after being fully informed about the study. Exclusion Criteria: 1. Periodontal treatment within the past six months. 2. Dental procedures (surgery, professional cleaning, scaling and root planing, laser therapy, piezotome) within the past six months. 3. Periodontitis, Stage IV. 4. Use of mouth rinses or oral gels within the past month. 5. Use of antibiotic therapy within the past three months. 6. Ongoing therapy with antihypertensives, antilipemics, antiarrhythmics, or other cardiovascular medications. 7. Systemic diseases such as diabetes, HIV/AIDS, liver diseases, chronic kidney disease, tuberculosis, and autoimmune disorders (e.g., lupus, scleroderma, Crohn's disease). 8. History of cardiovascular diseases, including acute myocardial infarction, angina pectoris, heart failure, atrial fibrillation, atrioventricular block, peripheral artery disease, or stroke. 9. Therapy with immunosuppressive agents. 10. Allergy to any ingredients of the study products. 11. Pregnant or breastfeeding women.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Periodontal disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

periodontal disorder periodontitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Periodontal disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    2 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Klinika Križaj Ljubljana

    RECRUITING

    Ljubljana, 1000, Slovenia

  • Ustna medicina d.o.o.

    RECRUITING

    Ljubljana, 1000, Slovenia

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.